Feature | March 07, 2014

Society of Interventional Radiology: Understand Long-term Risks of DVT

PTS complication can causes disability

Society of Interventional Radiology SIR Deep Vein Thrombosis DVT PTS Venous

March 7, 2014 — Deep vein thrombosis (DVT) often brings with it the risk of post-thrombotic syndrome (PTS), an under-recognized but serious complication that often causes long-term disability for patients. During March's DVT Awareness Month, the Society of Interventional Radiology wants to help patients and family members better understand the long-term risks of DVT.

DVT is a grave condition for which doctors have historically focused on its short-term risks. 

"For years, if someone developed deep vein thrombosis, his or her care was focused on reducing immediate harm using blood-thinning drugs,” said Suresh Vedantham, M.D., FSIR, an interventional radiologist and SIR service line officer. “However, the prevention of post-thrombotic syndrome, which is actually the primary determinant of a DVT patient's long-term quality of life, had been neglected. The evidence is mounting that interventional radiologists may soon transform the way we treat DVT in a way that improves patients' quality of life and prevents the debilitating consequences of post-thrombotic syndrome," said Vedantham, who is professor of radiology and surgery at Washington University School of Medicine in St. Louis, Mo.

Anticoagulants do not actively dissolve a blood clot; they just prevent new clots from forming, he explained. The body will sometimes eventually dissolve a clot, but often the vein becomes damaged. A significant proportion of DVT patients develop irreversible damage in the affected leg veins and their valves, resulting in abnormal pooling of blood in the leg, chronic leg pain, fatigue, swelling and, in extreme cases, severe skin ulcers.

"For a long time, doctors have believed that the use of compression stockings can prevent PTS; however, a rigorous study of compression stockings, published recently, shows that this is not the case," said Vedantham. 

On the other hand, a randomized trial evaluating the use of clot removal with interventional catheter-directed thrombolysis found a significant reduction in PTS. That is a treatment performed by interventional radiologists who guide a catheter or specialized device into a leg vein and thread it into the vein containing the clot and a "clot-busting" drug is infused directly into the clot. Since catheter-directed thrombolysis is most effective when performed within 14 days after DVT symptoms begin, he recommends that a second opinion from an interventional radiologist be sought if leg pain and swelling continue beyond seven days after treatment is started. 

"Individuals who received these treatments experienced fewer long-term symptoms and significantly less time lost from work," said Vedantham, who is also the principal investigator for the National Institutes of Health-sponsored ATTRACT Trial, the most rigorous United States-based study of these new treatments. 

In light of new research, SIR will also soon be issuing revised DVT guidelines that seek to improve the quality of care patients receive. During SIR's Annual Scientific Meeting March 22–27 in San Diego, attendees will hear about venous thromboembolic disease and acute DVT care and have the opportunity to take an in-depth look at complex issues in patients suffering from superficial and deep venous disease.

For more information: www.sirweb.org

Related Content

Toshiba, Infinix 4-D CT, first U.S. install, Arkansas cancer center
News | CT Angiography (CTA)| May 26, 2016
Cancer patients at the Carti Cancer Center, Conway, Ark., now have access to the latest innovation in diagnostic...
Technology | Stents Peripheral| April 27, 2016
Veniti Inc. announced the first successful treatment with the Vici Verto Venous Stent System of a patient suffering...
Auris Surgical Robotics, acquisition, Hansen Medical
News | Robotic Systems| April 26, 2016
Auris Surgical Robotics Inc. and Hansen Medical Inc. announced that they have signed a definitive merger agreement...
News | Interventional Radiology| April 25, 2016
The American Society of Radiologic Technologists (ASRT) has launched Vascular Interventional Essentials, a new...
Koven Technology, Smartdop XT vascular testing system,
Technology | Cardiac Diagnostics| March 30, 2016
The Smartdop XT by Koven is a fully automated vascular testing system that enables rapid, multiple-level bilateral...
Toshiba, ACC 2016, American College of Cardiology, CT, MR, ultrasound, angiography, interventional radiology

Infinix 4-D CT image courtesy of Toshiba America Medical Systems.

News | Cardiac Imaging| March 30, 2016
Toshiba America Medical Systems Inc. announced it would demonstrate the following diagnostic imaging technologies at...
Pulmonary embolism, toshiba

A pulmonary embolism visualized on a CTA scan using SureSubtraction software on a Toshiba Aquilion One Vision CT scanner. 

Feature | Pulmonary Embolism| March 28, 2016 | Alain T. Drooz, M.D., FSVM, and David J. Spinosa, M.D.
Acute pulmonary embolism (PE) can pose a major treatment quandary for clinicians.
NOACs, novel oral anticoagulants, VTE treatment, venous thromboembolism, GlobalData
News | Antiplatelet and Anticoagulation Therapies| March 21, 2016
The use of novel oral anticoagulants (NOACs) will see a substantial rise after an initially sluggish uptake and will...
Philips, Volcano, IVUS, vein obstruction diagnosis, multiplanar X-ray venography, VIDIO study
News | Intra-Vascular Ultrasound (IVUS)| February 29, 2016
Philips announced that new clinical trial data demonstrates the benefits of its intravascular ultrasound (IVUS)...
Artventive EOS embolization device, OCCLUDE post-market surveillance study, enrollment

Image courtesy of ArtVentive Medical Group Inc.

News | Embolization devices| February 24, 2016
ArtVentive Medical Group Inc. announced enrollment in the ongoing ArtVentive EOS Endoluminal Occlusion System, OCCLUDE...
Overlay Init